Cabot Corporation (NYSE:CBT) has earned a consensus recommendation of “Hold” from the ten brokerages that are covering the stock, MarketBeat.com reports. Five equities research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 1 year price target among brokerages that have covered the stock in the last year is $60.60.

Several analysts have weighed in on CBT shares. BidaskClub raised Cabot Corporation from a “sell” rating to a “hold” rating in a research note on Friday, June 16th. Zacks Investment Research raised Cabot Corporation from a “hold” rating to a “buy” rating and set a $60.00 target price on the stock in a research note on Tuesday, July 11th. ValuEngine downgraded Cabot Corporation from a “buy” rating to a “hold” rating in a research note on Friday, July 28th. J P Morgan Chase & Co raised Cabot Corporation from a “neutral” rating to an “overweight” rating and set a $57.00 target price on the stock in a research note on Tuesday, August 15th. Finally, Loop Capital started coverage on Cabot Corporation in a research note on Thursday, September 28th. They set a “hold” rating and a $59.00 target price on the stock.

Shares of Cabot Corporation (NYSE:CBT) traded up 0.75% on Wednesday, reaching $58.03. The company had a trading volume of 292,307 shares. The stock has a 50 day moving average price of $54.29 and a 200-day moving average price of $54.48. Cabot Corporation has a 12 month low of $47.99 and a 12 month high of $61.34. The company has a market capitalization of $3.61 billion, a price-to-earnings ratio of 16.25 and a beta of 1.09.

Cabot Corporation (NYSE:CBT) last announced its earnings results on Tuesday, August 1st. The specialty chemicals company reported $0.81 earnings per share for the quarter, missing the consensus estimate of $0.85 by ($0.04). The business had revenue of $705.00 million for the quarter, compared to the consensus estimate of $664.16 million. Cabot Corporation had a net margin of 8.61% and a return on equity of 16.03%. The firm’s revenue was up 13.5% on a year-over-year basis. During the same period in the previous year, the firm earned $0.93 EPS. Analysts forecast that Cabot Corporation will post $3.44 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: This story was originally posted by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another website, it was illegally copied and reposted in violation of U.S. & international copyright & trademark legislation. The correct version of this story can be viewed at https://www.americanbankingnews.com/2017/10/11/cabot-corporation-cbt-receives-average-rating-of-hold-from-brokerages.html.

In other news, insider Hobart Kalkstein sold 3,881 shares of Cabot Corporation stock in a transaction on Thursday, September 14th. The stock was sold at an average price of $53.39, for a total transaction of $207,206.59. Following the transaction, the insider now directly owns 27,736 shares in the company, valued at approximately $1,480,825.04. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 2.50% of the stock is currently owned by company insiders.

Several hedge funds have recently modified their holdings of the company. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its position in shares of Cabot Corporation by 0.4% during the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 9,118 shares of the specialty chemicals company’s stock valued at $487,000 after purchasing an additional 33 shares during the period. Teacher Retirement System of Texas increased its position in shares of Cabot Corporation by 0.9% during the 2nd quarter. Teacher Retirement System of Texas now owns 4,984 shares of the specialty chemicals company’s stock valued at $266,000 after purchasing an additional 45 shares during the period. Northwestern Mutual Investment Management Company LLC increased its position in shares of Cabot Corporation by 0.5% during the 2nd quarter. Northwestern Mutual Investment Management Company LLC now owns 10,772 shares of the specialty chemicals company’s stock valued at $492,000 after purchasing an additional 54 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Cabot Corporation by 9.2% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,469 shares of the specialty chemicals company’s stock valued at $132,000 after purchasing an additional 209 shares during the period. Finally, Capstone Asset Management Co. increased its position in shares of Cabot Corporation by 4.0% during the 2nd quarter. Capstone Asset Management Co. now owns 5,442 shares of the specialty chemicals company’s stock valued at $291,000 after purchasing an additional 210 shares during the period. Institutional investors own 84.28% of the company’s stock.

Cabot Corporation Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company. The Company operates through four business segments: reinforcement materials, performance chemicals, purification solutions and specialty fluids. Reinforcement materials’ rubber grade carbon blacks are used to enhance the physical properties of the systems and applications in which they are incorporated.

Analyst Recommendations for Cabot Corporation (NYSE:CBT)

Receive News & Ratings for Cabot Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot Corporation and related companies with MarketBeat.com's FREE daily email newsletter.